Diagnosing and Treating Onychomycosis

Zaias, Nardo; Glick, Brad; Rebell, Gerbert
May 1996
Journal of Family Practice;May96, Vol. 42 Issue 5, p513
Academic Journal
Onychomycosis is a persistent fungal infection of the toenails or fingernails that is usually not painful but is unsightly and can affect a patient's quality of life by interfering with footwear. It may affect up to 30% of the population by age 60. In more than 99% of cases, it is caused by dermatophytes, the most common of which are Trichophyton rubrum and Trichophyton mentagrophytes. Each of the four clinical types of onychomycosis, as defined by the route of fungal invasion, has a characteristic appearance, but other diseases, particularly psoriasis, may have a similar appearance. Proper management, therefore, includes confirmation of fungal infection by potassium hydroxide slide preparation and culture. Traditionally, pharmacologic treatment has been less than optimal. In many cases, griseofulvin, the first oral agent approved for onychomycosis in the United States, must be given for 1 year or more to be effective. Low cure rates are related to poor bioavailability and the fungistatic rather than fungicidal effect of the drug. Newer agents, such as oral itraconazole and oral terbinafine, promise to substantially increase cure rates while shortening treatment duration. Oral terbinafine is potently fungicidal against dermatophytes and has proven efficacious with regimens as brief as 12 weeks when the nail is not 100% involved.


Related Articles

  • Fungal nail dystrophy. Chittari, Kim; Ilchyshyn, Andrew // Update;Jul2007, Vol. 75 Issue 1, p21 

    The article presents information on the diagnosis and the topical and systemic antifungal therapy of nail infection. In onychomycosis, the concentration of fungus is highest in the nail bed. Sublingual debris should be collected from the most proximal and lateral portion of the affected nail bed...

  • Topical Solution for Nail Fungus. Preboth, Monica // American Family Physician;10/1/2001, Vol. 64 Issue 7, p1280 

    Reports on the approval of ciclopirox topical solution, 8 percent, for the treatment of onychomycosis by the United States Food and Drug Administration. Description of the solution and its use; Side effects.

  • Treating Onychomycosis. Rodgers, Phillip; Bassler, Mary // American Family Physician;2/15/2001, Vol. 63 Issue 4, p663 

    Onychomycosis accounts for one third of fungal skin infections. Because only about one half of nail dystrophies are caused by fungus, the diagnosis should be confirmed by potassium hydroxide preparation, culture or histology before treatment is started. Newer, more effective antifungal agents...

  • WystÄ™powanie i chorobotwórczość grzybów z rodzaju Scopulariopsis. Bochenek, Magdalena; Witalis, Jadwiga; Macura, Anna B. // Medical Mycology / Mikologia;2008, Vol. 15 Issue 2, p104 

    The genus Scopulariopsis contains 30 species, which sexual states (teleomorph) belong to the genus Microascus, Kernia and Pithoascus. Scopulariopsis sp. is a common soil saprophyte, but it is also isolated from plant, animal and human tissues. The genus Scopulariopsis exhibits ability to degrade...

  • GENETIC DIVERSITY AMONG IRANIAN CANDIDA ALBICANS ISOLATED FROM NAILS AND SKIN. Katiraee, Farzad; Shadi, Sahar; Farshi, Yashar; Fakhri, Omid; Zare, Payman // Jundishapur Journal of Microbiology;2013 Special Edition, p61 

    Introduction and Objectives: Candida albicans is the most prevalent yeast species that causes fungal infection. Also, C. albicans is one of the most frequent etiologic agents of dermatomycosis and onychomycosis. In spite of the new antifungals and health care, the incidence of mycoses has...

  • Treat onychomycosis topically or orally? Guzik, Joseph S.; H.C.N. // Cortlandt Forum;3/25/95, Vol. 8 Issue 3, p64 

    Presents suggestions for treating onychomycosis. Use of Mycocide (benzalkonium chloride) nail solution from Woodward Laboratories Inc.; Use of Naftin (naftifine hydrochloride) from Herbert Laboratories; Fluconazole.

  • Oral Antifungal-Exacerbated Inflammatory Flare-Up Reactions of Dermatomycosis: Case Reports and Review of the Literature. Nikkels, Arjen F.; Nikkels-Tassoudji, Nazli; Piérard, Gérald E. // American Journal of Clinical Dermatology;2006, Vol. 7 Issue 5, p327 

    Inflammatory flare-up reactions of some dermatomycoses, particularly those caused by zoophilic fungi, are typical and potentially severe adverse effects following the intake of some oral antifungals. However, this condition has not previously been reported with the most frequently used...

  • Canesten Combi.  // Royal Society of Medicine: Medicines;2002, p134 

    This article provides information on Canesten Combi, a proprietary, non-prescription preparation of the antifungal drug clotrimazole. It can be used to treat fungal and Candida skin infections, particularly vaginal thrush. It is available as a pack containing cream and a pessary with applicator...

  • Canesten Dermatological Powder.  // Royal Society of Medicine: Medicines;2002, p134 

    This article provides information on Canesten Dermatological Powder, a proprietary, non-prescription preparation of the antifungal drug clotrimazole. It can be used to treat fungal and Candida skin infections, such as sweat rash, jock itch, ringworm, nappy rash and body infections. It is...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics